Hisamitsu Pharmaceutical Co., Inc. (TYO: 4530)
Japan
· Delayed Price · Currency is JPY 4,119.00
+38.00 (0.93%)
Dec 20, 2024, 3:45 PM JST
Hisamitsu Pharmaceutical Co. Cash Flow Statement
Financials in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 31, 2024 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | Feb '20 Feb 29, 2020 | 2019 - 2015 |
| Net Income | 20,649 | 19,186 | 16,113 | 12,956 | 12,197 | 26,155 | Upgrade
|
| Depreciation & Amortization | 5,688 | 5,172 | 4,952 | 4,321 | 4,079 | 4,251 | Upgrade
|
| Loss (Gain) From Sale of Assets | 852 | 852 | -319 | 55 | -177 | 908 | Upgrade
|
| Loss (Gain) From Sale of Investments | -2,692 | -389 | 257 | -653 | -188 | 176 | Upgrade
|
| Loss (Gain) on Equity Investments | -470 | -585 | -424 | -569 | -133 | -786 | Upgrade
|
| Other Operating Activities | -4,221 | -3,954 | -5,311 | -119 | -7,719 | -2,851 | Upgrade
|
| Change in Accounts Receivable | -8,500 | -2,082 | 780 | 2,191 | 8,955 | -9,422 | Upgrade
|
| Change in Inventory | -1,891 | -1,628 | -1,581 | 3,073 | -4,325 | 232 | Upgrade
|
| Change in Accounts Payable | 4,632 | 686 | 653 | -2,196 | -3,812 | 4,944 | Upgrade
|
| Change in Other Net Operating Assets | 4,546 | 930 | -2,393 | 140 | -3,588 | 3,788 | Upgrade
|
| Operating Cash Flow | 18,593 | 18,188 | 12,727 | 19,199 | 5,289 | 27,395 | Upgrade
|
| Operating Cash Flow Growth | 49.75% | 42.91% | -33.71% | 263.00% | -80.69% | 73.69% | Upgrade
|
| Capital Expenditures | -18,279 | -12,924 | -7,859 | -3,610 | -3,341 | -3,698 | Upgrade
|
| Sale of Property, Plant & Equipment | 186 | 186 | 1,004 | 37 | 642 | 74 | Upgrade
|
| Sale (Purchase) of Intangibles | -138 | -112 | -49 | -583 | -47 | -28 | Upgrade
|
| Investment in Securities | 16,296 | 17,109 | -16,966 | -8,918 | 9,604 | -13,581 | Upgrade
|
| Other Investing Activities | -6,780 | -6,773 | - | 12 | 955 | -2 | Upgrade
|
| Investing Cash Flow | -8,713 | -2,512 | -23,868 | -13,060 | 7,815 | -17,229 | Upgrade
|
| Short-Term Debt Repaid | - | -4 | - | -40 | -100 | -150 | Upgrade
|
| Long-Term Debt Repaid | - | -66 | -71 | -77 | -69 | -67 | Upgrade
|
| Total Debt Repaid | -64 | -70 | -71 | -117 | -169 | -217 | Upgrade
|
| Net Debt Issued (Repaid) | -64 | -70 | -71 | -117 | -169 | -217 | Upgrade
|
| Repurchase of Common Stock | -17,362 | -9,796 | -7,694 | -8,043 | -2 | -4,520 | Upgrade
|
| Dividends Paid | -6,508 | -6,578 | -6,719 | -6,839 | -6,806 | -6,836 | Upgrade
|
| Other Financing Activities | -266 | -247 | -203 | -190 | -210 | -153 | Upgrade
|
| Financing Cash Flow | -24,200 | -16,691 | -14,687 | -15,189 | -7,187 | -11,726 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1,752 | 1,957 | 5,005 | 3,944 | -1,559 | -225 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -1 | -1 | 1 | - | -1 | -1 | Upgrade
|
| Net Cash Flow | -12,569 | 941 | -20,822 | -5,106 | 4,357 | -1,786 | Upgrade
|
| Free Cash Flow | 314 | 5,264 | 4,868 | 15,589 | 1,948 | 23,697 | Upgrade
|
| Free Cash Flow Growth | -85.80% | 8.13% | -68.77% | 700.26% | -91.78% | 95.10% | Upgrade
|
| Free Cash Flow Margin | 0.21% | 3.71% | 3.79% | 12.97% | 1.70% | 16.81% | Upgrade
|
| Free Cash Flow Per Share | 4.17 | 68.36 | 61.31 | 191.82 | 23.82 | 288.13 | Upgrade
|
| Cash Interest Paid | 27 | 18 | 15 | 20 | 9 | 19 | Upgrade
|
| Cash Income Tax Paid | 4,298 | 4,017 | 5,333 | 505 | 7,320 | 2,941 | Upgrade
|
| Levered Free Cash Flow | -10,553 | -2,703 | 10,116 | 12,213 | 1,680 | 20,548 | Upgrade
|
| Unlevered Free Cash Flow | -10,536 | -2,692 | 10,126 | 12,226 | 1,686 | 20,560 | Upgrade
|
| Change in Net Working Capital | 6,418 | 3,058 | -5,831 | -6,262 | 5,675 | -5,829 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.